Paul Tudor Jones’s iShares Biotechnology ETF IBB Stock Holding History

Paul Tudor Jones’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.18M	Buy	+16,732	New	+$2.88M	﹤0.01%	1602
2026 Q1	–	Sell	-8,963	Closed	-$1.51M	–	3928
2025 Q4	$1.51M	Buy	8,963 +2,513	+39%	+$408K	﹤0.01%	2009
2025 Q3	$931K	Buy	+6,450	New	+$880K	﹤0.01%	2320
2025 Q2	–	Sell	-1,723	Closed	-$220K	–	3470
2025 Q1	$220K	Buy	+1,723	New	+$234K	﹤0.01%	2807
2024 Q4	–	Sell	-9,423	Closed	-$1.37M	–	3235
2024 Q3	$1.37M	Sell	9,423 -2,634	-22%	-$381K	0.01%	1435
2024 Q2	$1.65M	Buy	+12,057	New	+$1.61M	0.01%	1179
2024 Q1	–	Sell	-8,224	Closed	-$1.12M	–	2454
2023 Q4	$1.12M	Buy	+8,224	New	+$1M	0.01%	1385
2022 Q1	–	Sell	-1,465	Closed	-$224K	–	2304
2021 Q4	$224K	Buy	+1,465	New	+$227K	﹤0.01%	2078
2021 Q3	–	Sell	-2,166	Closed	-$354K	–	2611
2021 Q2	$354K	Buy	+2,166	New	+$334K	0.01%	1292
2017 Q3	–	Sell	-234,000	Closed	-$24.2M	–	1165
2017 Q2	$24.2M	Buy	+234,000	New	+$23M	0.74%	18
2017 Q1	–	Sell	-300,000	Closed	-$26.5M	–	1455
2016 Q4	$26.5M	Buy	+300,000	New	+$27.3M	0.68%	17

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Paul Tudor Jones's IBB Position: Q2 2026 in Review

Paul Tudor Jones opened a new position in iShares Biotechnology ETF (IBB) in Q2 2026: 16,732 shares worth $3.18M. The stake represents ﹤0.01% of the portfolio and ranks #1602 among its holdings. This is a return to the name: Paul Tudor Jones previously reported a position in IBB as recently as Q4 2025.

Paul Tudor Jones first reported a position in IBB in Q4 2016 and has held it in 11 quarters since. The position peaked at $26.5M in Q4 2016. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Paul Tudor Jones held 16,732 shares of iShares Biotechnology ETF worth $3.18M as of Q2 2026.
iShares Biotechnology ETF was a new Paul Tudor Jones position in Q2 2026.
iShares Biotechnology ETF made up ﹤0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #1602 holding.
Paul Tudor Jones first reported a position in iShares Biotechnology ETF in Q4 2016 and has held it in 11 quarters since.
Paul Tudor Jones's iShares Biotechnology ETF position peaked at $26.5M in Q4 2016.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.